• Nenhum resultado encontrado

Rev. Bras. Reumatol. vol.57 número5

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Reumatol. vol.57 número5"

Copied!
3
0
0

Texto

(1)

r e v b r a s r e u m a t o l . 2017;57(5):472–474

ww w . r e u m a t o l o g i a . c o m . b r

REVISTA

BRASILEIRA

DE

REUMATOLOGIA

Case

report

Coexistence

of

hypertrophic

osteoarthropathy

and

myelofibrosis

Coexistência

de

osteoartropatia

hipertrófica

e

mielofibrose

Bayram

Kelle

a,∗

,

Fatih

Yıldız

b

,

Semra

Paydas

c

,

Emine

Kılıc

Bagır

d

,

Melek

Ergin

d

,

Erkan

Kozanoglu

a

aCukurovaUniversity,FacultyofMedicine,DepartmentofPhysicalMedicineandRehabilitation,Adana,Turkey

bCukurovaUniversity,FacultyofMedicine,DepartmentofRheumatology,Adana,Turkey

cCukurovaUniversity,FacultyofMedicine,DepartmentofOncology,Adana,Turkey

dCukurovaUniversity,FacultyofMedicine,DepartmentofPathology,Adana,Turkey

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received1September2014 Accepted2November2014 Availableonline28January2015

Introduction

Hypertrophicosteoarthropathy(HOA)isaconditionpresented byarthralgia/arthritis,clubbing,andperiostealproliferation (periostitis)inlongbones.Itisclassifiedasprimary(hereditary oridiopathic)andsecondary.PrimaryHOAisarareand hered-itaryconditionobservedmainlyinchildrenandadolescents.1 SecondaryHOAmaybeseeninthevarioussystemicdisorders includinginflammatoryandmaligndiseases.Clinicalfindings developasaresultofanincreaseinperipheralbloodflowas wellasabnormalfibroblastactivityandproliferation.2–4

Myelofibrosisisachronicmyeloproliferativedisease char-acterizedbyclonalexpansionofanabnormalhematopoietic stem/progenitorcell.5Thereareafewcasereportsregarding

ThisstudywasoriginatedinCukurovaUniversity,FacultyofMedicine,DepartmentofPhysicalMedicineandRehabilitation,Adana, Turkey.

Correspondingauthor.

E-mail:bayramkelle@yahoo.com(B.Kelle).

thecoexistenceofmyelofibrosiswithHOA.Herewepresenta caseofHOAcoexistedwithmyelofibrosis.

Case

report

Sixty-fiveyearsoldmaleadmittedtoPhysicalMedicineand RehabilitationOutpatientClinicduetoincreasedpainatboth lowerextremitiesforthepreceedingyear.Hewasdiagnosed myelofibrosisasaresultaftermedicalhistory,routineblood tests and bone marrow biopsy 6 years ago. Bone marrow aspiration wasdry,andexaminationofthebiopsy revealed a hypoplastic marrow with myelofibrosis (Fig. 1A and B). Patientreceivedinterferon(IFN)alfa2Aduring2yearsandhis bonemarrowwasinremissionafterthistreatment.Although

http://dx.doi.org/10.1016/j.rbre.2014.11.004

(2)

r e v b r a s r e u m a t o l . 2017;57(5):472–474

473

Fig.1–Bonemarrowbiopsyshowsreticulin-typemyelofibrosis(hematoxylinandeosin,100×).Bonemarrowbiopsyshows

reticulin-typemyelofibrosis(reticulin,100×).

patient’s painhasincreasedwhilemoving, it hasalso per-sistedatrest.Patienthadbenefitedfromanalgesicmedication initiallybuthestatedthathispainincreasedovertime,and notresolvedwithanalgesics.Onthe physicalexamination, patient’sgeneralstatuswaswell.Bloodpressure was mea-suredas125/75mmHg,andpulseratewas78min–1.Clubbing was observed at both hands. Both tibias were painful by percussion, and tibial margins were palpated as irregular. Althoughpainwaspresentatanklesandknees,no temper-aturerise or synovitiswere detected. Range ofmotion for bilateralhip,kneeandanklejointswerewithinthenormal limits.

Conventional X-ray of the cruris region demonstrated periostealreactionatbothtibialbonewhichismore promi-nentontheleftside(Fig.2).Wholebodybonescintigraphy demonstratedincreaseduptakeatdistalpartoflefttibia.In laboratoryanalysis,hemoglobin,whitebloodcellandplatelet countswerewithinnormallimits,whileMCVwasdecreased [69.5fL–(N:80–97–)].Peripheralbloodsmearwasassessedas

Fig.2–Periostealreaction(periostitis)atthetibialmargin (blackarrow).

normal.Therewasnotanincreaseinacutephasereactants. Erythrocytesedimentationratewas20mm/h(N:0–15)andCRP waswithinnormalrange[<0.5ng/L(N:0–0.8)].Parathyroid hor-mone,calciumand25-hydroxyvitaminD3levelswerewithin normal limits.SerumIL-6 and TNFalfa levelswere within normalrange.

Diagnosis was madeas secondary HOAassociatedwith myelofibrosis. Patient was recommended to receive oral meloxicam15mgdaily.Becauseoftheincompleteresponse aftersevendays,colchicine1mg/daywasaddedtothe treat-ment,andsignificantdecreaseofpainwasdetectedafterone week.

Discussion

HOAisaclinicalsyndromecharacterizedbydigitalclubbing andperiostalproliferationespeciallyinthetibialbone.1HOA includesskinmanifestationssuchasthickenedskinonface and scalp, and coarse facial features along with clubbing, periostosis,acroosteolysis,andpainfuljointmotion.6

HOAmaybeassociatedwithvariousdisorders including intrathoracicmalignancies,cyanoticheartdiseases, gastroin-testinaltumorsandinflammatoryboweldiseases.1Oneofthe rarecausesofsecondaryHOAismyelofibrosis.

(3)

474

r e v b r a s r e u m a t o l . 2017;57(5):472–474

ofthelimitationsofthiscasereportwasthelackoflaboratory testsincludingPDGF,TGFandVEGF.Nevertheless, TNF-alfa andIL-6levelswerenegativeinourpatient.

HOAassociatedwithmyelofibrosisisobservedrarelyand alimitednumberofcasereportsarepresentedinthe litera-ture.Yuetal.presentedtwomalewithHOAassociatedwith myelofibrosis.Theysuggestedthatperiostitis,when associ-atedwithfeverandbonepain,isindicativeofmoreaggressive disease.10 In several case reports of HOA associated with myelofibrosisithasbeenreportedthattheacutephase reac-tantswerehigher.2,3,7Ourpatienthadnotfeverandtherewas noevidenceofincreasedacutephaseproteins.Thesepoints maybeassociatedwiththemilderdiseasecourseofourcase. ThereisnoevidenceintheliteratureregardingthatIFN causesclinicallyovertHOA.ButIFNtherapymaycause club-bing in some patients. There was only a published report consistingtwopatientswhohadclubbingassociatedwiththe use ofIFN treatment.11 Itwas reportedthat IFNtreatment causesabnormalfibroblastactivationandthisconditionmay bethecauseclubbing.Inthiscasereporttwopatientswere presentedwhoreceivedIFNalfa2AforhepatitisCvirus.Digital clubbingwasdevelopedafterthe2ndand4thmonthsof med-icationinthesepatients,respectively.Incontrast,ourpatient wasdevelopeddigitalclubbing andtibial bonepainafter2 yearsofmedication.Nevertheless,therewasaperiosteal reac-tioninbothtibialbonesinadditiontoclubbinginthecurrent casewhichprovidedthediagnosisofHOA.

Thereisnoconsensusonthestandardtreatmentregimen ofHOA.Afavorableresulttothecombination ofcolchicine andmeloxicamwasobservedinthepresentcase.Inthe liter-ature,ithasbeenreportedthatpamidronatehasbeenfound tobeeffectiveinosteoarthropatiesnotrespondingto nonste-roidalanti-inflammatorydrugs.Octreotidetreatmenthasalso yieldedsimilarresults.12

Inconclusion, patients who had diffusejoint pain with unknowncauseshouldbecheckedforcomorbidconditions andadditionaldiseases.Inaddition,HOAshouldbesuggestive incasespresentedwithatypicallocalizedpainandclubbing alreadywhohadmyelofibrosiseitherinactiveorremission period.However,itshouldbenotedthatallclinicalfindings may not be observed in cases of secondary or associated HOA.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

r

e

f

e

r

e

n

c

e

s

1.AhrenstorfG,RihlM,PichlmaierMA,RosenthalH,WitteT, SchmidtRE.Unilateralhypertrophicosteoarthropathyina patientwithavasculargraftinfection.JClinRheumatol. 2012;18:307–9.

2.ArıkanS,SenI,BahceciM,TuzcuA,AvliM.Aninteresting caseofpachydermoperiostosiswithidiopathicmyelofibrosis associatedwithmonosomy22.IntJDermatol.2009;48:882–5. 3.MassoudS,AzitaA,NajmehN.Primaryhypertrophic

osteoarthropathywithmyelofibrosis.RheumatolInt. 2008;28:597–600.

4.NarayananS,MohamedGaniVM,SundararajuV.Primary hypertrophicosteoarthropathywithhypertrophic gastropathy.JClinRheumatol.2010;16:190–2.

5.BarbuiT,FinazziG,FalangaA.Myeloproliferativeneoplasms andthrombosis.Blood.2013;122:2176–84.

6.ZhangZ,XiaW,HeJ,ZhangZ,KeY,YueH,etal.Exome sequencingidentifiesSLCO2A1mutationsasacauseof primaryhypertrophicosteoarthropthy.AmJHumGenet. 2012;90:125–32.

7.KumarU,BhattSP,MisraA.Unusualassociationsof pachydermoperiostosis:acasereport.IndianJMedSci. 2008;62:65–8.

8.JohnB,SubhashH,ThomasK.Caseofmyelofibrosiswith hypertrophicosteoarthropathy:theroleofplatelet-derived growthfactorinpathogenesis.NZMedJ.2004;117:U853. 9.RendinaD,DeFillipoG,VicencotiR,SosciaE,SiriqnanoC,

SalvatoreM,etal.Interleukin(IL)-6andreceptoractivatorof nuclearfactor(NF)-kappaBligand(RANKL)areincreasedin theserumofapatientwithprimarypachydermoperiostosis. ScandJRheumatol.2008;37:225–9.

10.YuJS,GreenwayG,ResnickD.Myelofibrosisassociatedwith prominentperiostealboneapposition.Reportoftwocases. ClinImaging.1994;18:89–92.

11.AlamMT,SheikhSS,AzizS,MasroorM.Anunusualside effectofinterferonalfa2A:digitalclubbing.JAyubMedColl Abbottabad.2008;20:165–6.

Imagem

Fig. 2 – Periosteal reaction (periostitis) at the tibial margin (black arrow).

Referências

Documentos relacionados

This is an open access article is properly cited and distributed under the terms and conditions of creative commons attribution license which permits unrestricted use,

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any

This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any

This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any

(2014) The Cellular Prion Protein Negatively Regulates Phagocytosis and Cytokine Expression in Murine Bone Marrow-Derived Macrophages.. This is an open-access article distributed

This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which

This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )... 372 rev bras